Chemoimmunotherapy is the standard first-line option approach for CLL, the most common leukemia observed in adults. Treatment is initiated when the disease becomes symptomatic, and survival is high following treatment.
No takes yet. Share an insight, caveat, or question.
Nabhan et al. (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: